title: Radioimmunotherapy of lymphoma: an underestimated therapy option.
authors.affiliation: Department of Hematology and Oncology, Kantonspital Graubünden, CH-7000 Chur, Switzerland; Deparment of Hematology and Medical Oncology, Georg August University, 37099 Goettingen, Germany. Electronic address: karo.hohloch@med.uni-goettingen.de.
authors.forename: Karin
authors.initials: K
authors.lastname: Hohloch
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D000074322:Antineoplastic Agents, Immunological / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D006801:Humans; D018796:Immunoconjugates / Q000627:therapeutic use; D008223:Lymphoma / Q000628:therapy*; D011241:Prednisone / Q000627:therapeutic use; D016499:Radioimmunotherapy; D000069283:Rituximab; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D058846:Antibodies, Monoclonal, Murine-Derived; D000074322:Antineoplastic Agents, Immunological; D018796:Immunoconjugates; C571759:R-CHOP protocol; C448700:epratuzumab; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone